Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Total Assets : ¥4,287 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co Total Assets?

Shanghai Kaibao Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥4,287 Mil.

During the past 12 months, Shanghai Kaibao Pharmaceutical Co's average Total Assets Growth Rate was -14.70% per year. During the past 3 years, the average Total Assets Growth Rate was 38.00% per year. During the past 5 years, the average Total Assets Growth Rate was 22.90% per year. During the past 10 years, the average Total Assets Growth Rate was 9.90% per year.

During the past 13 years, Shanghai Kaibao Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 52.90%. The lowest was -10.00%. And the median was 27.80%.

Total Assets is connected with ROA %. Shanghai Kaibao Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 7.98%. Total Assets is also linked to Revenue through Asset Turnover. Shanghai Kaibao Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.11.

Shanghai Kaibao Pharmaceutical Co Total Assets Historical Data

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kaibao Pharmaceutical Co Total Assets Chart

Shanghai Kaibao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

2,842.50

2,877.28

3,355.82

4,259.27

4,579.67

Shanghai Kaibao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															4,757.64	4,529.99	4,402.54	4,579.67	4,286.99

Shanghai Kaibao Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shanghai Kaibao Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	4032.856	+	546.817
	=	4,580

Shanghai Kaibao Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	3779.696	+	507.294
	=	4,287

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Total Assets Explanation

Total Assets is connected with ROA %.

Shanghai Kaibao Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	353.836	/	( (4579.673	+	4286.989)	/ 2 )
	=	353.836	/	4433.331
	=	7.98 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shanghai Kaibao Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	475.497	/	( (4579.673	+	4286.989)	/ 2 )
=	475.497	/	4433.331
=	0.11

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shanghai Kaibao Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401

Website

http://www.xykb.com

Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.

Executives

Liu Shao Yong	Supervisors
Ren Li Wang	Secretary Dong
Zhang Tao	Executives
Mu Jing Wei	Director
Li Xiu Hai	Directors, executives
Zhang Lian Xin	Supervisors
Han Jing	Independent director
Wang Guo Ming	Directors, executives
Wang Chong Bang	Executives
Liu Yi Shan	Director
Li Qing Wei	Independent director
Mu Lai An	Director
Zhu Ying Jun	Executives
Chang Qing Ling	Supervisors
Zhang Peng	Director

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Headlines

No Headlines